Sturgis Bancorp, Inc. Declares Quarterly Cash Dividend

STURGIS, MI / ACCESS Newswire / January 27, 2025 / Sturgis Bancorp, Inc. (OTCQX:STBI) today announced that its Board of Directors has declared a cash dividend of $0.17 per common share, payable March 14, 2025, to stockholders of record at the close of business on February 14, 2025. This declaration continues the quarterly dividend at […]

Noa Tishby, Israeli Activist and Emmanuel Acho, Modern Thought Leader, Unite for “Uncomfortable Conversations” Event

David Posnack Jewish Community Center Presents "Uncomfortable Conversations" at Barry University: A Thought-Provoking Discussion on Confronting Division and Stereotypes MIAMI, FL / ACCESS Newswire / January 27, 2025 / The David Posnack Jewish Community Center in Davie is hosting "Uncomfortable Conversations" with Noa Tishby and Emmanuel Acho on Thursday, February 27, 2025, at 7:30 PM

Bronstein, Gewirtz & Grossman, LLC Is Investigating Electronic Arts Inc. (EA) And Encourages Stockholders to Connect

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Electronic Arts Inc. ("EA" or "the Company") (NASDAQ:EA). Investors who purchased EA securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/EA. Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating TELUS International (Cda) Inc. (TIXT) And Encourages Stockholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TELUS International (Cda) Inc. ("TELUS" or "the Company") (NYSE:TIXT). Investors who purchased TELUS securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:

JKS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into JinkoSolar Holding Co., Ltd. and Encourages Investors to Contact the Firm

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of JinkoSolar Holding Co., Ltd. ("JinkoSolar" or "the Company") (NYSE:JKS). Investors who purchased JinkoSolar securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/JKS.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Walgreens Boots Alliance, Inc. (WBA) and Encourages Investors to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Walgreens Boots Alliance, Inc. ("Walgreens" or "the Company") (NASDAQ:WBA). Investors who purchased Walgreens securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site:

Bronstein, Gewirtz & Grossman, LLC Encourages Keros Therapeutics, Inc. (KROS) Stockholders to Inquire about Securities Investigation

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Keros Therapeutics, Inc. ("Keros" or "the Company") (NASDAQ:KROS). Investors who purchased Keros securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/KROS. Investigation

FTAI Aviation Ltd. Is Being Sued For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESS Newswire / January 27, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FTAI Aviation Ltd. ("FTAI Aviation" or "the Company") (NASDAQ:FTAI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated

Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation

Revolutionary Oral Interferon Technology Combines Unmatched Advantages and Global Potential in the $16 Billion Coronavirus Market SAN DIEGO, CA / ACCESS Newswire / January 27, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") proudly announces the granting of a pivotal invention patent in Japan (Patent No. 7619659) for its groundbreaking oral interferon formulation, VELDONA®,